Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03KDO
|
|||
| Former ID |
DNCL003679
|
|||
| Drug Name |
Prochymal
|
|||
| Indication | Acute radiation syndrome [ICD-11: NF00; ICD-10: T66] | Phase 3 | [1] | |
| Crohn disease [ICD-11: DD70; ICD-10: K50, K50.9] | Phase 3 | [1] | ||
| Graft-versus-host disease [ICD-11: 4B24] | Phase 3 | [1] | ||
| Heart disease [ICD-11: BA41-BA42; ICD-10: I21, I22; ICD-9: 410] | Phase 3 | [2] | ||
| Company |
Osiris Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00482092) Evaluation of PROCHYMAL Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01233960) Evaluation of PROCHYMAL for Treatment-refractory Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.